Florida Attorney General James Uthmeier has filed a state-court action against Pfizer and its CEO, Albert Bourla, alleging the company misled consumers about the safety and effectiveness of Pfizer’s COVID-19 vaccine. The suit adds a high-profile state enforcement action to the already complex body of litigation stemming from pandemic-era vaccine marketing, and it could become a closely watched test of how far state consumer-protection laws can reach in disputes over pharmaceutical communications.

At its core, the case appears to frame vaccine-related statements not simply as scientific or regulatory matters, but as actionable representations to consumers.